CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −3,156 | $28.91 | $91K | 113,106 |
| 2024-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −7,108 | 7,109 | ||
| 2024-02-20 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +1,872 | 7,100 | ||
| 2024-02-20 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −641 | $30.39 | $19K | 6,459 |
| 2024-02-20 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −1,872 | 0 | ||
| 2024-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +3,901 | 70,193 | ||
| 2024-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,379 | $30.39 | $42K | 68,814 |
| 2024-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −3,901 | 0 | ||
| 2024-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,461 | 277,345 | ||
| 2024-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −1,606 | $30.39 | $49K | 275,739 |
| 2024-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −5,461 | 0 | ||
| 2024-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +4,680 | 149,634 | ||
| 2024-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −2,078 | $30.39 | $63K | 147,556 |
| 2024-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −4,680 | 0 | ||
| 2024-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +10,297 | 103,180 | ||
| 2024-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −4,572 | $30.39 | $139K | 98,608 |
| 2024-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −10,297 | 0 | ||
| 2024-02-20 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,177 | 159,370 | ||
| 2024-02-20 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,994 | $30.39 | $91K | 156,376 |
| 2024-02-20 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,177 | 0 |
Page 27 of 41 · 804 trades